Improvement of pulmonary absorption of cyclopeptide FK224 in rats by co-formulating with beta-cyclodextrin.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2003-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0939-6411(02)00158-3PMID 12637090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pulmonary Delivery of Salmon Calcitonin Dry Powders Containing Absorption Enhancers in Rats

  2004cited by this paper
• Rates of protein transport across rat alveolar epithelial cell monolayers.

  2000cited by this paper
• Cyclodextrin-based controlled drug release system.

  1999cited by this paper
• Cyclodextrins in nasal drug delivery.

  1999cited by this paper
• Beclomethasone/cyclodextrin inclusion complex for dry powder inhalation

  1999cited by this paper
• Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing.

  1999cited by this paper
• Cyclodextrins in peptide and protein delivery.

  1999cited by this paper
• Pulmonary Bioavailability of a Phosphorothioate Oligonucleotide (CGP 64128A): Comparison with Other Delivery Routes

  1998cited by this paper
• Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.

  1998cited by this paper
• Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery

  1997cited by this paper
• Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various absorption enhancers and their pulmonary toxicity in rats.

  1997cited by this paper
• The Influence of Sodium Glycocholate and Other Additives on the in vivo Transfection of Plasmid DNA in the Lungs

  1996cited by this paper
• Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery.

  1996cited by this paper
• Pulmonary absorption of recombinant human growth hormone in rats

  1996cited by this paper
• Pulmonary absorption enhancement of peptides by absorption enhancers and protease inhibitors

  1996cited by this paper
• Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

  1996cited by this paper
• Study on Pulmonary Delivery of Salmon Calcitonin in Rats: Effects of Protease Inhibitors and Absorption Enhancers

  1994cited by this paper
• Administration as hydroxypropyl β-cyclodextrin complexes does not slow rates of pulmonary drug absorption in rat

  1994cited by this paper
• Absorption of an RGD peptide (SK & F 106760) following intratracheal administration in rats

  1994cited by this paper
• Cyclodextrins as mucosal absorption promoters of insulin. III: Pulmonary route of delivery

  1994cited by this paper
• Bioavailability of pulmonary delivered peptides and proteins: α-interferon, calcitonins and parathyroid hormones

  1994cited by this paper
• Intratracheal delivery of insulin Absorption from solution and aerosol by rat lung

  1992cited by this paper
• Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats

  1991cited by this paper
• Studies of cyclodextrin inclusion complexes. III. The pulmonary absorption of β-, DM-β- and HP-β-cyclodextrins in rabbits

  1991cited by this paper
• Studies of cyclodextrin inclusion complexes. IV. The pulmonary absorption of salbutamol from a complex with 2-hydroxypropyl-β-cyclodextrin in rabbits

  1991cited by this paper
• Bioavailability of powdered inclusion compounds of nonsteroidal antiinflammatory drugs with beta-cyclodextrin in rabbits and dogs.

  1978cited by this paper
• Phase solubility techniques

  1965cited by this paper

• Cyclodextrin-based materials for pulmonary delivery: Insights and challenges.

  2025cites this paper
• Inhalation of Tetrandrine- hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment.

  2020cites this paper
• Brain Targeting of Acyl-CoA:Cholesterol O-Acyltransferase-1 Inhibitor K-604 via the Intranasal Route Using a Hydroxycarboxylic Acid Solution

  2019cites this paper
• Computational intelligence for prediction of biological effects of drugs absorption in lungs

  2019cites this paper
• Design and characterization of emulsified spray dried alginate microparticles as a carrier for the dually acting drug roflumilast

  2018cites this paper
• Polymer‐based Delivery Systems for the Pulmonary Delivery of Biopharmaceuticals

  2015cites this paper
• Validation of an HPLC Analytical Method for the Quantitative/Qualitative Determination of Fluticasone Propionate in Inhalation Particles on Several Matrices

  2014cites this paper
• The Impact of Aspergillus fumigatus Viability and Sensitization to Its Allergens on the Murine Allergic Asthma Phenotype

  2013cites this paper
• A comparison between intratracheal and inhalation delivery of Aspergillus fumigatus conidia in the development of fungal allergic asthma in C57BL/6 mice.

  2011cites this paper
• Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.

  2011cites this paper
• Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats.

  2011cites this paper
• Cyclodextrins: an overview of the complexation of pharmaceutical proteins.

  2010cites this paper
• Effect of pulmonary surfactant and phospholipid hexadecanol tyloxapol on recombinant human-insulin absorption from intratracheally administered dry powders in diabetic rats.

  2010cites this paper
• Comparison of solid dispersions produced by supercritical antisolvent and spray-freezing technologies.

  2009cites this paper
• Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/cyclodextrin inclusion complexes.

  2009cites this paper
• Dose tolerability of chronically inhaled voriconazole solution in rodents.

  2009cites this paper
• Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties

  2009cites this paper
• Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.

  2009cites this paper
• Characterization and pharmacokinetic analysis of aerosolized aqueous voriconazole solution.

  2009cites this paper
• In vitro toxicity and permeation of cyclodextrins in Calu-3 cells.

  2008cites this paper
• Improvement of transmucosal absorption of protein and peptide drugs by cyciodextrins

  2008cites this paper
• Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.

  2007cites this paper
• Improvement of pulmonary absorption of insulin and other water-soluble compounds by polyamines in rats.

  2007cites this paper
• In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A.

  2006cites this paper
• Improvement in the variation of inhalation properties of an FK888 dry powder inhaler using an E-haler, by adding coarse lactose in spherical soft agglomerates of fine drug particles, and its absorption in healthy volunteers

  2005cites this paper
• Carrier-based strategies for targeting protein and peptide drugs to the lungs

  2005cites this paper
• Formulation development of inhalation powders for FK888 using the E-haler to improve the inhalation performance at a high dose, and its absorption in healthy volunteers.

  2005cites this paper
• Formulation development of inhalation powders for FK888 with carrier lactose using Spinhaler and its absorption in healthy volunteers.

  2004cites this paper
• Comparison of the lung absorption of FK224 inhaled from a pressurized metered dose inhaler and a dry powder inhaler by healthy volunteers.

  2003cites this paper